These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6459008)

  • 1. Some behavioural interactions between 5-hydroxytryptamine and dopamine.
    Curzon G
    Adv Exp Med Biol; 1981; 133():563-84. PubMed ID: 6459008
    [No Abstract]   [Full Text] [Related]  

  • 2. Behavioural responses to drugs releasing 5-hydroxytryptamine and catecholamines: effects of treatments altering precursor concentrations in brain.
    Fernando JC; Curzon G
    Neuropharmacology; 1981 Feb; 20(2):115-22. PubMed ID: 7207710
    [No Abstract]   [Full Text] [Related]  

  • 3. Backward walking and circling: behavioural responses induced by drug treatments which cause simultaneous release of catecholamines and 5-hydroxytryptamine.
    Curzon G; Fernando JC; Lees AJ
    Br J Pharmacol; 1979 Aug; 66(4):573-9. PubMed ID: 465894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of 5-hydroxytryptamine and dopamine neurones in the behavioural effects of alpha-methylytryptamine.
    Marsden CA
    Neuropharmacology; 1980 Aug; 19(8):691-8. PubMed ID: 6448356
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological differentiation of the central 5-hydroxytryptamine-like actions of MK-212 (6-chloro-2[1-piperazinyl]-pyrazine),p-methoxyamphetamine and fenfluramine in an in vivo model system.
    Clineschmidt BV; McGuffin JC
    Eur J Pharmacol; 1978 Aug; 50(4):369-75. PubMed ID: 151629
    [No Abstract]   [Full Text] [Related]  

  • 6. Some 5-hydroxytryptamine-like actions of fenfluramine: a comparison with (+)-amphetamine and diethylpropion.
    Southgate PJ; Mayer SR; Boxall E; Wilson AB
    J Pharm Pharmacol; 1971 Aug; 23(8):600-5. PubMed ID: 4397744
    [No Abstract]   [Full Text] [Related]  

  • 7. p-Chloroamphetamine-induced hyperthermia pharmacologically distinct from fenfluramine-induced hyperthermia.
    Quock RM; Weick BG
    J Pharm Pharmacol; 1979 Jan; 31(1):27-32. PubMed ID: 32362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of various serotonin releasing agents in mice.
    Hwang EC; Van Woert MH
    Biochem Pharmacol; 1980 Dec; 29(23):3163-7. PubMed ID: 6449931
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship of the central effect of dopamine on gnawing compulsion syndrome in rats and the release of serotonin.
    Ernst AM
    Arch Int Pharmacodyn Ther; 1972 Oct; 199(2):219-25. PubMed ID: 4262736
    [No Abstract]   [Full Text] [Related]  

  • 10. Roles of dopamine and 5-hydroxytryptamine in stereotyped and non-stereotyped behaviour.
    Dickinson SL; Curzon G
    Neuropharmacology; 1983 Jul; 22(7):805-12. PubMed ID: 6225959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenfluramine-induced enhancement of confinement motor activity: an indirect 5-hydroxytryptamine-like action?
    Clineschmidt BV; McGuffin JC; Pflueger AB; Totaro JA
    Neuropharmacology; 1975 Apr; 14(4):301-11. PubMed ID: 124023
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of serotonergic stimulation on hippocampal and neocortical slow waves and behavior.
    Robertson B; Baker GB; Vanderwolf CH
    Brain Res; 1991 Aug; 555(2):265-75. PubMed ID: 1933339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of serotonin-releasing drugs on serum corticosterone concentration in rats.
    Fuller RW; Snoddy HD
    Neuroendocrinology; 1980 Aug; 31(2):96-100. PubMed ID: 6446690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of antiserotonergic agents on the action of dopaminergic drugs.
    Mogilnicka E; Scheel-Krüger J; Klimek V; Golembiowska-Nikitin K
    Pol J Pharmacol Pharm; 1977; 29(1):31-8. PubMed ID: 140371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of d-amphetamine and d-fenfluramine on performance of rats in a food maze.
    Rech RH; Borsini F; Samanin R
    Pharmacol Biochem Behav; 1984 Apr; 20(4):489-93. PubMed ID: 6728866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Hydroxytryptamine: the effects of impaired synthesis on its metabolism and release in rat.
    Curzon G; Fernando JC; Marsden CA
    Br J Pharmacol; 1978 Aug; 63(4):627-34. PubMed ID: 80243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the behavioural effects of tryptophan and rho-chlorophenylalanine.
    Marsden CA; Curzon G
    Neuropharmacology; 1976 Mar; 15(3):165-71. PubMed ID: 132618
    [No Abstract]   [Full Text] [Related]  

  • 18. Elevation of serum prolactin acutely after administration of p-chloroamphetamine in rats.
    Fuller RW; Snoddy HD; Clemens JA
    Endocr Res Commun; 1980; 7(2):77-85. PubMed ID: 6447591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenfluramine and 5-hydroxytryptamine. Part 2: Involvement of brain 5-hydroxytryptamine in the anorectic activity of fenfluramine.
    Duhault J; Boulanger M; Voisin C; Malen C; Schmitt H
    Arzneimittelforschung; 1975 Nov; 25(11):1758-62. PubMed ID: 128366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological studies on serotonin-mediated behaviour.
    Green AR
    J Physiol (Paris); 1981; 77(2-3):437-47. PubMed ID: 6457143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.